Neogen Gelecekteki Büyüme

NasdaqGS:NEOG - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (USD Millions )
Tarih	Gelir	Kazançlar	Serbest Nakit Akışı	Faaliyetlerden Nakit	Avg. Analist Sayısı
5/31/2027	1,032	39	N/A	N/A	2
5/31/2026	984	20	N/A	N/A	2
5/31/2025	936	-2	N/A	N/A	2
8/31/2024	912	-24	-125	-6	N/A
5/31/2024	924	-9	-76	35	N/A
2/29/2024	929	2	-13	99	N/A
11/30/2023	919	12	17	113	N/A
8/31/2023	919	-27	-5	78	N/A
5/31/2023	822	-23	-25	41	N/A
2/28/2023	721	-13	-82	-30	N/A
11/30/2022	631	-16	-50	-6	N/A
8/31/2022	531	36	-5	31	N/A
5/31/2022	527	48	44	68	N/A
2/28/2022	514	49	50	70	N/A
11/30/2021	503	57	54	75	N/A
8/31/2021	487	62	55	79	N/A
5/31/2021	468	61	54	81	N/A
2/28/2021	450	61	58	85	N/A
11/30/2020	433	60	71	93	N/A
8/31/2020	426	61	65	87	N/A
5/31/2020	418	59	62	86	N/A
2/29/2020	419	59	62	81	N/A
11/30/2019	417	60	51	72	N/A
8/31/2019	416	60	52	71	N/A
5/31/2019	414	60	49	64	N/A
2/28/2019	413	62	49	66	N/A
11/30/2018	410	65	57	74	N/A
8/31/2018	403	66	48	67	N/A
5/31/2018	398	63	N/A	69	N/A
2/28/2018	389	58	N/A	62	N/A
11/30/2017	382	52	N/A	58	N/A
8/31/2017	372	46	N/A	59	N/A
5/31/2017	358	44	N/A	60	N/A
2/28/2017	353	41	N/A	53	N/A
11/30/2016	341	39	N/A	44	N/A
8/31/2016	330	37	N/A	49	N/A
5/31/2016	321	37	N/A	35	N/A
2/29/2016	310	36	N/A	38	N/A
11/30/2015	301	35	N/A	41	N/A
8/31/2015	290	34	N/A	40	N/A
5/31/2015	283	34	N/A	44	N/A
2/28/2015	272	32	N/A	38	N/A
11/30/2014	265	31	N/A	34	N/A
8/31/2014	256	29	N/A	27	N/A
5/31/2014	247	28	N/A	22	N/A
2/28/2014	236	28	N/A	24	N/A
11/30/2013	225	28	N/A	26	N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: NEOG önümüzdeki 3 yıl içerisinde kârlı hale gelmesi öngörülüyor; bu da tasarruf oranından ( 2.5% ) daha hızlı bir büyüme olarak değerlendiriliyor.

Kazançlar ve Piyasa: NEOG önümüzdeki 3 yıl içerisinde karlı hale gelmesi öngörülüyor ki bu da ortalama piyasa büyümesinin üzerinde kabul ediliyor.

Yüksek Büyüme Kazançları: NEOG önümüzdeki 3 yıl içinde karlı hale gelmesi bekleniyor.

Gelir ve Pazar: NEOG şirketinin gelirinin (yıllık 4.6% ) US pazarından (yıllık 8.9% ) daha yavaş büyümesi öngörülüyor.

Yüksek Büyüme Geliri: NEOG şirketinin gelirinin (yıllık 4.6% ) yıllık 20% oranından daha yavaş büyümesi öngörülüyor.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: NEOG 'un Özsermaye Getirisi'nin 3 yıl içinde yüksek olmasının öngörülüp öngörülmediğini belirlemek için yeterli veri yok

Neogen Gelecekteki Büyüme

Future kriter kontrolleri 3/6

Anahtar bilgiler

Gelecekteki son büyüme güncellemeleri

Neogen Corporation Provides Earnings Guidance for the Year 2025

Price target decreased by 11% to US$17.00

Consensus EPS estimates have been downgraded.

Neogen Corporation Just Reported A Surprise Loss: Here's What Analysts Think Will Happen Next

Neogen Corporation Updates Earnings Guidance for the Full Year 2024

Consensus EPS estimates fall by 25%

Recent updates

President exercised options to buy US$400k worth of stock.

President exercised options to buy US$344k worth of stock.

Neogen Stock: Expect Volatility To Continue Amid Weak Growth

First quarter 2025 earnings: EPS misses analyst expectations

Neogen Corporation Announces That Douglas E. Jones Communicated His Intent to Retire in Early 2025

Neogen Appoints Thierry Bernard as Director, Effective November 1, 2024

Neogen Corporation to Report Q1, 2025 Results on Oct 10, 2024

Neogen Corporation, Annual General Meeting, Oct 24, 2024

Risks To Shareholder Returns Are Elevated At These Prices For Neogen Corporation (NASDAQ:NEOG)

Neogen Corporation Provides Earnings Guidance for the Year 2025

Full year 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

We Think Neogen (NASDAQ:NEOG) Is Taking Some Risk With Its Debt

Neogen Corporation to Report Q4, 2024 Results on Jul 30, 2024

Neogen Corporation: Challenges Remain

There's Reason For Concern Over Neogen Corporation's (NASDAQ:NEOG) Price

Neogen® Launches New Molecular Method for Detection of Two Salmonella Serotypes

Price target decreased by 11% to US$17.00

Consensus EPS estimates have been downgraded.

Battered By M&A Integration Issues, Neogen Has To Rebuild Investor Trust

Neogen Corporation Just Reported A Surprise Loss: Here's What Analysts Think Will Happen Next

Neogen®? Farm Fluid Max Disinfectant Launches Across Great Britain Livestock & Poultry Markets

President recently bought US$284k worth of stock

Third quarter 2024 earnings: EPS misses analyst expectations

Neogen Corporation Updates Earnings Guidance for the Full Year 2024

Neogen Corporation Announces Board Changes

Neogen (NASDAQ:NEOG) Takes On Some Risk With Its Use Of Debt

Neogen: All About Execution From Here On

Neogen Corporation to Report Q3, 2024 Results on Apr 09, 2024

Consensus EPS estimates fall by 25%

Neogen® Releases Surekill® Gel Bait Pro Applicator

Statutory Profit Doesn't Reflect How Good Neogen's (NASDAQ:NEOG) Earnings Are

Neogen Corporation Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecasts

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Neogen Corporation (NASDAQ:NEOG) Investors Are Less Pessimistic Than Expected

Neogen Corporation Provides Earnings Guidance for the Fiscal Year 2024

Neogen Corporation to Report Q2, 2024 Results on Jan 09, 2024

Here's Why Neogen (NASDAQ:NEOG) Can Manage Its Debt Responsibly

Neogen®? Launches Highly Sensitive Quantitative Elisa Assay for the Detection of Walnut Allergens

Price target decreased by 14% to US$22.25

Neogen Corporation Provides Revenue Guidance for the Fiscal Year 2024

Neogen Corporation to Report Q1, 2024 Results on Oct 10, 2023

Neogen Corporation, Annual General Meeting, Oct 25, 2023

Neogen® Launches Igenity® Enhanced Dairy

Neogen Corporation Unveils over 100 New Genetic Tests

Neogen Corporation announced delayed annual 10-K filing

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Neogen Corporation to Report Q4, 2023 Results on Jul 27, 2023

Neogen (NASDAQ:NEOG) Has A Somewhat Strained Balance Sheet

Is There An Opportunity With Neogen Corporation's (NASDAQ:NEOG) 46% Undervaluation?

Neogen Corporation Launches DNA Test for Beef-on-Dairy Cattlec

Neogen Corporation Launches New Assays for Histamine Detection

Neogen Corporation Launches New Assays for Natural Toxin Detection

Third quarter 2023 earnings: EPS exceeds analyst expectations

Neogen (NASDAQ:NEOG) Has A Somewhat Strained Balance Sheet

Second quarter 2023 earnings: EPS misses analyst expectations

Neogen Corporation to Report Q2, 2023 Results on Jan 05, 2023

Price target decreased to US$14.00

Neogen Corporation Launches Synergize Disinfectant in Europe, the Middle East, Africa

Neogen Corporation Launches Ready-To-Use Chemiluminescent Substrate

Investor sentiment improved over the past week

Association of Official Analytical Chemists Approves Neogen Corporation's Megazyme Rapid Integrated Total Dietary Fiber Assay as the Standard Method

VP & CFO recently bought US$58k worth of stock

Investor sentiment deteriorated over the past week

Neogen Corporation Adds Companion™ Ready-To-Use Disinfectant to Biosecurity Portfolio

Neogen introduces ready-to-use disinfectant Companion RTU for veterinary use

Neogen Corporation Launches New Genomic Management Technology

President recently bought US$316k worth of stock

Neogen Corporation Announces Executive Changes

Neogen GAAP EPS of $0.05, revenue of $132.35M